Hedge Funds Are Dumping GlaxoSmithKline plc (ADR) (GSK)

GlaxoSmithKline plc (ADR) (NYSE:GSK) was in 18 hedge funds' portfolio at the end of March. GSK investors should be aware of a decrease in enthusiasm from smart money lately.

Keep Reading →